SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950162-02-000384
Filing Date
2002-03-12
Accepted
2002-03-12 00:00:00
Documents
1
Group Members
DEFIANTE FARMACEUTICA UNIPOSSOAL, L.D.A.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sigma13g031202.txt SC 13G 13498
  Complete submission text file 0000950162-02-000384.txt   15486
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37837 | Film No.: 02573581
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA SUDAFRICA 20 00144 ROME ITALY
Business Address VIA SUDAFRICA 20 00144 ROME ITALY
SIGMA TAU FINANZIARIA (Filed by) CIK: 0001092601 (see all company filings)

Fiscal Year End: 1231